Challenges in determining the global burden of non-malignant central nervous system tumors: An analysis of international incidence and mortality data sources
Neuro-Oncology · 2025
DOI: 10.1093/neuonc/noaf006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2025. Verfasst von Frances Dean und 15 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Boston University, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, St. Jude Children's Research Hospital Comprehensive Cancer Center, St. Jude Children’s Research Hospital Comprehensive Cancer Center.
Abstract (Originalsprache)
Background
Non-malignant tumors of the CNS contribute substantially to the morbidity and mortality from CNS tumors. It is critical to understand the epidemiology of non-malignant CNS tumors separately from CNS malignancies to inform resource allocation and policy since treatment and prognosis can differ. High-quality international data on non-malignant CNS tumor burden are needed to accomplish this goal.
Methods
We assessed the cancer registry and vital registration data available to the Global Burden of Disease study by its inclusion of non-malignant CNS tumors, reporting on the availability of data over time and by the World Bank income group. We analyzed preliminary age-standardized incidence rates (ASIRs), age-standardized mortality rates (ASMRs), and proportions of CNS tumors by behavior for adults, children, and all ages.
Results
Non-malignant CNS tumors were reported separately in 17.2% (N = 66) of registry reports and in aggregate with malignant CNS tumors in 18.0% (N = 69) of reports. Only 7 low- and middle-income countries (LMICs) had data reporting CNS tumors separately by behavior. Across all ages combined, the median ASIR of non-malignant CNS tumor data was 0.31 (interquartile range: 0.15–0.50) and ASMR was 0.24 (0.10–0.44) per 100,000 in LMICs compared to median ASIR of 3.62 (2.62–4.97) and ASMR of 0.32 (0.16–0.65) in high-income countries (HICs). A larger proportion of incident CNS tumors were reported as non-malignant in HIC data than LMIC data (P < .0001).
Conclusions
Our study alludes to current challenges in understanding global non-malignant CNS tumor burden and a need for increased international data collection. Further research is needed to comprehensively investigate opportunities for future data inclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, Boston University, Boston, Massachusetts, USA.
- Institute for Health Metrics and Evaluation, Population Health Building/Hans Rosling Center, University of Washington, Seattle, Washington, USA.
- Computational Precision Health, University of California, Berkeley, Berkeley, California, USA.
- Computational Precision Health, University of California, San Francisco, San Francisco, California, USA.
- Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
- Division of Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
ORCID-Profile: Frances Dean
Förderung
- NCI NIH HHS
- St. Jude Children's Research Hospital Comprehensive Cancer Center
- St. Jude Children’s Research Hospital Comprehensive Cancer Center
Zitieren
APA
Dean, F., Henrikson, H., Xu, R., Farah, H., Lu, D., Harvey, J., Fu, W., Pritchett, N., Bhakta, N., Moreira, D. C., Qaddoumi, I., Girardi, F., Vos, T., Naghavi, M., Finlay, J. L., & Force, L. M. (2025). Challenges in determining the global burden of non-malignant central nervous system tumors: An analysis of international incidence and mortality data sources. Neuro-Oncology. https://doi.org/10.1093/neuonc/noaf006
Vancouver
Dean F, Henrikson H, Xu R, Farah H, Lu D, Harvey J, et al. Challenges in determining the global burden of non-malignant central nervous system tumors: An analysis of international incidence and mortality data sources. Neuro-Oncology. 2025. doi:10.1093/neuonc/noaf006
BibTeX
@article{Dean2025,
author = {Dean, Frances and Henrikson, Hannah and Xu, Rixing and Farah, Hodo and Lu, Dan and Harvey, James and Fu, Weijia and Pritchett, Natalie and Bhakta, Nickhill and Moreira, Daniel C and Qaddoumi, Ibrahim and Girardi, Fabio and Vos, Theo and Naghavi, Mohsen and Finlay, Jonathan L and Force, Lisa M},
title = {Challenges in determining the global burden of non-malignant central nervous system tumors: An analysis of international incidence and mortality data sources},
journal = {Neuro-Oncology},
year = {2025},
doi = {10.1093/neuonc/noaf006}
}
EUVIMED